Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance.
- NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance.
- NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_assertion evidence source_evidence_literature NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance.
- NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_assertion SIO_000772 19106083 NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance.
- NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_assertion wasDerivedFrom befree-20150227 NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance.
- NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_assertion wasGeneratedBy ECO_0000203 NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance.
- befree-20150227 importedOn "2015-02-27" NP341618.RAkEX4QbJMd1N2f-WvcBBhDrtp8sWGN6UdUV7oNVo569s130_provenance.